Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study groupLena Weiss, Michael Haas, Thomas Hoehler et al.|ESMO Open|2024Cited by 3
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?Lena Weiss, Michael Haas, Volker Heinemann et al.|Clinical & Translational Oncology|2023Cited by 2